:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Aakash Desai, Priya Sehgal, Himsikhar Khataniar, James D. Lewis, Francis A. Farraye, Gary R. Lichtenstein, Gursimran S. Kochhar
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	https://onlinelibrary.wiley.com/doi/10.1111/apt.18513
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis—The Fat of the Matter: Authors' Reply
by: Aakash Desai, et al.
Published: (2025)

Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
by: Aakash Desai, et al.
Published: (2024)

Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis
by: Arshdeep Singh, et al.
Published: (2025)

Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis—The Fat of the Matter
by: Anish J. Kuriakose Kuzhiyanjal, et al.
Published: (2025)

Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT‐UC Consortium
by: Parambir S. Dulai, et al.
Published: (2024)

Editorial: Evolving Trends in Ulcerative Colitis Management—Insights From the Lothian Cohort
by: Shintaro Akiyama
Published: (2025)

Editorial: Dual Advanced Therapy in Refractory Ulcerative Colitis—Hope Beyond Monotherapy
by: Ahmed B. Bayoumy, et al.
Published: (2025)

Letter: Steroid Tapering in Ulcerative Colitis: The Importance of Disease Severity and Maintenance Therapy
by: Rónán O'Connor, et al.
Published: (2026)

Editorial: Striving for Equitable Care in Ulcerative Colitis
by: Edward L. Barnes
Published: (2025)

Letter: Temporal Trends in the Rate of Colectomy in Ulcerative Colitis
by: Richard Pollok
Published: (2025)

Meta‐Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis
by: Matthew K. W. Chu, et al.
Published: (2025)

Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
by: Antoine Meyer, et al.
Published: (2025)

The Association of Faecal Calprotectin Measurements With Endo‐Histological Remission in Ulcerative Colitis: A Pooled Analysis
by: Laurie‐Rose Dubé, et al.
Published: (2026)

Efficacy and Safety of Vedolizumab and Tofacitinib ( VETO ) Combination Therapy in Refractory Ulcerative Colitis Unresponsive to Anti‐ TNF and a Second‐Line Advanced Therapy: A Prospective Cohort Nested Within a Randomised Trial
by: Pardhu Bharath Neelam, et al.
Published: (2025)

Letter: Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
by: Zhidong Zhou, et al.
Published: (2025)

Temporal Trends in Medical and Surgical Management of Ulcerative Colitis in England: 2003–2020
by: J. Couch, et al.
Published: (2025)

Editorial: The Appendix—A Dead End for Treating Ulcerative Colitis, After All?
by: Johan D. Söderholm
Published: (2025)

Letter: Exclusive Enteral Nutrition in Ulcerative Colitis—The Path Ahead Needs Careful Consideration
by: Sarah Melton, et al.
Published: (2025)

Editorial: Real‐World Effectiveness of Mirikizumab in Ulcerative Colitis—A Valuable but Preliminary Glimpse
by: Mark A. Ainsworth, et al.
Published: (2025)

Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study
by: Saqr Alsakarneh, et al.
Published: (2025)

Letter: Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT ‐ UC Consortium
by: Brian C. Weiner
Published: (2025)

Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study
by: Tom van Gils, et al.
Published: (2024)

Letter: Thiopurines the Silent Workhorse for Many Patients After a Flare of Ulcerative Colitis. Authors' Reply
by: Ankit Kumar, et al.
Published: (2026)

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
by: Mathilde Osty, et al.
Published: (2025)

Editorial: Effectiveness and Safety of Ustekinumab in Ulcerative Colitis—Where We Are Now in Real Life. Authors' Reply
by: María Chaparro, et al.
Published: (2024)

Editorial: Real‐World Effectiveness of Mirikizumab in Ulcerative Colitis—A Valuable but Preliminary Glimpse. Authors' Reply
by: Shinichiro Shinzaki, et al.
Published: (2025)

Editorial: Ulcerative Colitis Management in the Biologic Era–Data From the English Healthcare Databases. Authors' Reply
by: J. Couch, et al.
Published: (2025)

Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors. Authors' Reply
by: Merle Claßen, et al.
Published: (2024)

Letter: A Patient Centric Approach to Tapering Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis
by: Ganesh Bhat, et al.
Published: (2026)

Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises But the Usual Suspects Need Greater Attention
by: Weilun Gao, et al.
Published: (2024)

Long‐Term Outcomes of an Infliximab‐First Versus Vedolizumab‐First Treatment Strategy in Biologic‐Naïve Patients With Ulcerative Colitis
by: Austin Haynesworth, et al.
Published: (2024)

Clinical Trial: Evaluating a Single 1600 mg Tablet Regimen of 5‐Aminosalicylate for Ulcerative Colitis—The EASI Trial
by: Rie Louise Møller Nordestgaard, et al.
Published: (2025)

Letter: A Patient Centric Approach to Tapering Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis. Authors' Reply
by: Amol N. Patil, et al.
Published: (2026)

Clinical Trial: Long Versus Short Tapering of Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis—A Randomised Controlled Trial
by: Ankit Kumar, et al.
Published: (2026)

Clinical Trial: Association Between Early Disease Clearance and Long‐Term Outcomes—4‐Year Results From the Phase 3 UNIFI Study of Ustekinumab in Ulcerative Colitis
by: Silvio Danese, et al.
Published: (2025)

Letter : Is Short Tapering of Steroids in Moderate to Severely Active Ulcerative Colitis Really Inferior to a Long Steroid Taper, or Just Underpowered to Reach a Definitive Conclusion?
by: Hariti Saluja, et al.
Published: (2026)

Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial
by: Kanika Sehgal, et al.
Published: (2024)

Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
by: Saqr Alsakarneh, et al.
Published: (2025)

Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score‐Matched Study Using Linear Mixed‐Effects Models
by: Takashi Kumada, et al.
Published: (2026)

Editorial: Association of Antibiotic Exposure With Microscopic Colitis—Authors' Reply
by: Máté Szilcz, et al.
Published: (2025)